Financial News
Latest News about BNTX
Recent news which mentions BNTX
From Benzinga
China begins to loosen COVID rules
December 05, 2022
From MarketWatch
BioNTech, Vertex Pharmaceuticals And Other Big Biotechnology Stocks From Benzinga's Most Accurate Analysts
December 02, 2022
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
December 01, 2022
From Benzinga
BioNTech, Ryvu Therapeutics Join Forces For Immuno-Modulatory Candidates
November 30, 2022
Tickers
BNTX
From Benzinga
Quant Ratings Updated on 59 Stocks
November 29, 2022
From InvestorPlace
IMF head joins chorus calling on China to adapt COVID strategy as officials pledge to boost vaccinations among elderly
November 29, 2022
From MarketWatch
China’s zero-COVID strategy makes no sense and its homegrown vaccines are not ‘particularly effective,’ says Fauci
November 28, 2022
From MarketWatch
2 Biotech Stocks You Can Buy and Hold for the Next Decade
November 28, 2022
From Motley Fool
Is Novavax Stock a Buy Now?
November 26, 2022
From Motley Fool
From Benzinga
Researchers Working On Universal mRNA-Influenza Vaccine Aiming For Baseline Immune Memory For Diverse Strains
November 25, 2022
From Benzinga
Is Now the Time for Income Investors to Buy This Big Pharma Stock?
November 24, 2022
From Motley Fool
7 Stocks on the Perfect 10 List
November 23, 2022
Tags
Stocks to Buy
NYSE:ALB,NASDAQ:BNTX,NASDAQ:INMD,NASDAQ:MRNA,NYSE:SQM,NASDAQ:VRTX,NYSE:VIST,NYSE:MRK
VIST
From InvestorPlace
PFE Stock Could Be the Booster Shot Your Portfolio Needs Now
November 23, 2022
From InvestorPlace
Jim Cramer Says China's Vaccines 'Don't Work' But Xi Won't Admit It
November 22, 2022
From Benzinga
Confused about COVID boosters? Here’s what the science and the experts say about the new generation of shots.
November 22, 2022
From MarketWatch
2 Reasons to Buy Pfizer and 1 Reason to Sell
November 20, 2022
From Motley Fool
After Bill Gates Dumps Billions In Berkshire To Buy Microsoft, His Quiet Biotech Portfolio Has Made A New Trade
November 18, 2022
From Benzinga
7 Stocks to Sell Right Now… and 1 to Buy
November 18, 2022
From InvestorPlace
Pfizer/BioNTech's Omicron Tailored COVID-19 Vaccine Shows Improved Immune Response Against Emerging Omicron Sublineages
November 18, 2022
From Benzinga
Pfizer and BioNTech updated booster shows strong results against new omicron sublineages in fresh analysis of data
November 18, 2022
From MarketWatch
From Benzinga
Pfizer, BioNTech Start Work On Next-Gen COVID-19 Vaccine Candidate For Broader Protection
November 17, 2022
From Benzinga
Third COVID-19 Booster or Fifth Dose Not Required Despite Surge In Cases, Australian Health Authorities Say
November 15, 2022
From Benzinga
BioNTech Plans To Set Up Singapore Based mRNA Plant By End Of 2023
November 14, 2022
From Benzinga
Repeat COVID-19 Infection Increases Risk Of Acute Outcomes, Long COVID Symptoms, Study Shows
November 11, 2022
From Benzinga
Europe Approves Sanofi, GSK's Beta Variant Adapted COVID Shot As Booster
November 10, 2022
From Benzinga
WHO says 90% decline in COVID deaths since Feb. is ’cause for optimism,’ while urging vigilance against new variants
November 10, 2022
From MarketWatch
This COVID-19 Vaccine Stock Has More to Offer
November 10, 2022
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
